The Effect of Case Management in Complex Cancer Pathways
2 other identifiers
interventional
280
1 country
1
Brief Summary
Introduction: Case management (CM) has been proposed as a method for optimizing the course of treatment for complicated cancer patients. However evidence of the effect of CM is limited and methodologically rigorous research is needed. Aim: To analyze effects of Nurse CM in complicated cancer care. Methods: The study is designed as a two-arm randomized controlled trial (RCT) including approximately 280 colorectal cancer patients. Intervention group patients will be offered usual medical treatment plus supportive intervention from a case manager. Control group patients will receive usual medical and supportive treatment. The intervention: Case managers are registered nurses and possess thorough knowledge of cancer treatment and pathways. Core intervention elements: Planned and ad hoc personal and telephone contacts, surveillance of care pathways, coordination and dissemination of care plan (including transfer of patient-specific information to other departments and general practice). Primary outcomes: Patient evaluations of care pathways and "Quality of Life" (questionnaires). Secondary outcomes: Use of health care services and care process measures (The National Health Insurance Service Registry and The National Patient Registry; and GPs' evaluations of continuity of care (questionnaire). Schedule:
- "Case management used to optimize cancer care pathways: A systematic Review" has been published in BMC Health Services Research.
- The CM manual has been written. Questionnaires are under development and pilot testing.
- Two case managers have been appointed 1. January 2009.
- After training and pilot testing of the intervention the RCT will begin in March 2009. Inclusion period is 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2009
CompletedFirst Posted
Study publicly available on registry
February 18, 2009
CompletedStudy Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedAugust 31, 2012
August 1, 2012
1.8 years
February 13, 2009
August 30, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient satisfaction with care pathways(questionnaire)
8, 30 and 52 weeks after inclusion and randomization
Quality of Life measures(questionnaire)
8, 30 and 52 weeks after inclusion and randomization
Secondary Outcomes (3)
Use of health care services during "the secondary care treatment period", i.e. GPs, emergency department, planned and emergency admission, total length of hospitalisation
12 (and 6) months from diagnosis
GPs' evaluations of continuity of care (questionnaire).
30 weeks after the patient's inclusion in the trial
Care process measures in terms of monitoring of data from the National Patient Registry
12 (and 6) months after diagnosis
Study Arms (2)
Control
PLACEBO COMPARATORControl group patients will receive usual medical plus usual supportive treatment.
Case management
ACTIVE COMPARATORIntervention group patients are offered the support of a nurse case manager throughout their course of treatment.
Interventions
Intervention group patients are offered the support of a nurse case manager throughout their course of treatment.
Eligibility Criteria
You may qualify if:
- Colon or rectal cancer are highly suspected and a course of treatment at Department P, Aarhus University Hospital is expected to follow.
You may not qualify if:
- Do not speak and understand Danish sufficiently to fill out questionnaires (due to dementia, some foreigners etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Research Unit for General Practice, Aarhus Universitycollaborator
- The Research Council for Health and Disease, Denmarkcollaborator
- Danish Cancer Societycollaborator
- Novo Nordisk A/Scollaborator
- Kvalitets- og efteruddannelsesudvalget for Region Midtjyllandcollaborator
Study Sites (1)
Department P, Aarhus University Hospital
Aarhus C, 8000, Denmark
Related Publications (1)
Wulff CN, Vedsted P, Sondergaard J. A randomised controlled trial of hospital-based case management to improve colorectal cancer patients' health-related quality of life and evaluations of care. BMJ Open. 2012 Nov 21;2(6):e001481. doi: 10.1136/bmjopen-2012-001481. Print 2012.
PMID: 23175735DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian N Wulff, MD
Research Unit of General Practice, Odense
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2009
First Posted
February 18, 2009
Study Start
March 1, 2009
Primary Completion
January 1, 2011
Study Completion
January 1, 2012
Last Updated
August 31, 2012
Record last verified: 2012-08